✦ LIBER ✦

Mortality in patients with Parkinson's disease

✍ Scribed by L. Wermuth; E. N. Stenager; E. Stenager; J. Boldsen

Book ID: 114784397
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 408 KB
Volume: 92
Category: Article
ISSN: 0001-6314
DOI: 10.1111/j.1600-0404.1995.tb00466.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of physical exercise on mortality

Effect of physical exercise on mortality in patients with Parkinson's disease

✍ K. Kuroda; K. Tatara; T. Takatorige; F. Shinsho 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 440 KB

Impairment of brain vessels may contribu

Impairment of brain vessels may contribute to mortality in patients with Parkinson's disease

✍ Ivan Rektor; David Goldemund; Petr Bednařík; Kateřina Sheardová; Zuzana Michálko 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB

Mortality in patients with Parkinson's d

Mortality in patients with Parkinson's disease treated by stimulation of the subthalamic nucleus

✍ Michael W.M. Schüpbach; Marie Laure Welter; Anne Marie Bonnet; Alexis Elbaz; Bra 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB 👁 1 views

## Abstract Subthalamic nucleus (STN) stimulation improves motor disability and quality of life in patients with advanced Parkinson's disease (PD). Short‐term mortality is low, but little is known about long‐term mortality. We assessed mortality and causes of death in 171 consecutive PD patients tr

Mortality and cancer incidence in patien

Mortality and cancer incidence in patients with Parkinson's disease

✍ Yuko Minami; Reiko Yamamoto; Mitsuaki Nishikouri; Akira Fukao; Shigeru Hisamichi 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 116 KB

Long-term efficacy and mortality in Park

Long-term efficacy and mortality in Parkinson's disease patients treated with subthalamic stimulation

✍ Mathias Toft; Bård Lilleeng; Jon Ramm-Pettersen; Inger Marie Skogseid; Vidar Gun 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 678 KB

## Background: The objective of this study was to examine the clinical outcome and mortality of long-term deep brain stimulation of the subthalamic nucleus in advanced parkinson's disease. ## Methods: We included all 144 patients (mean age, 60.3 years; mean disease duration, 11.0 years) treated i

Survival time, mortality, and cause of d

Survival time, mortality, and cause of death in elderly patients with Parkinson's disease. A 9-year follow-up

✍ Per-Arne Fall; Avin Saleh; Mats Fredrickson; Jan-Edvin Olsson; Ann-Kathrine Gran 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB 👁 1 views

## Abstract This community‐based study of Parkinson's disease (PD) investigated age at death and cause of death in a cohort of 170 previously studied patients. The current study is a 9‐year follow‐up, and the results are compared to 510 sex‐ and age‐matched controls from the same area. A total of 1